Jonathan Courtland Carlson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperhidrosis | 1 | 2024 | 35 | 0.940 |
Why?
|
Fluorescent Dyes | 7 | 2022 | 1915 | 0.920 |
Why?
|
Cyclooctanes | 6 | 2022 | 32 | 0.860 |
Why?
|
Paresthesia | 2 | 2019 | 162 | 0.790 |
Why?
|
Tetrazoles | 2 | 2018 | 835 | 0.720 |
Why?
|
Delusions | 2 | 2019 | 300 | 0.720 |
Why?
|
Tetrahydrofolate Dehydrogenase | 4 | 2012 | 143 | 0.670 |
Why?
|
Fatigue | 1 | 2024 | 1526 | 0.570 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1835 | 0.510 |
Why?
|
Click Chemistry | 4 | 2022 | 95 | 0.510 |
Why?
|
Boron Compounds | 2 | 2015 | 178 | 0.440 |
Why?
|
Methotrexate | 3 | 2012 | 1720 | 0.380 |
Why?
|
Single-Cell Analysis | 5 | 2022 | 2183 | 0.320 |
Why?
|
Heterocyclic Compounds | 2 | 2022 | 249 | 0.310 |
Why?
|
Staining and Labeling | 4 | 2023 | 1099 | 0.270 |
Why?
|
Nanostructures | 2 | 2008 | 550 | 0.250 |
Why?
|
Sweat | 1 | 2024 | 49 | 0.240 |
Why?
|
Sweating | 1 | 2024 | 123 | 0.230 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3564 | 0.200 |
Why?
|
Ecchymosis | 1 | 2021 | 32 | 0.200 |
Why?
|
Molecular Structure | 2 | 2018 | 1907 | 0.200 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 206 | 0.190 |
Why?
|
Prodrugs | 1 | 2022 | 268 | 0.190 |
Why?
|
Kinetics | 4 | 2022 | 6474 | 0.180 |
Why?
|
Erythrocyte Indices | 1 | 2020 | 146 | 0.180 |
Why?
|
Anemia, Pernicious | 1 | 2019 | 19 | 0.170 |
Why?
|
Molecular Probes | 1 | 2020 | 316 | 0.170 |
Why?
|
Salivary Gland Neoplasms | 1 | 2022 | 297 | 0.160 |
Why?
|
Pyridazines | 1 | 2020 | 201 | 0.160 |
Why?
|
Exosomes | 1 | 2023 | 412 | 0.160 |
Why?
|
Hemophilia A | 1 | 2021 | 351 | 0.160 |
Why?
|
Fluorescent Antibody Technique | 1 | 2022 | 2505 | 0.150 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2018 | 136 | 0.150 |
Why?
|
Hand | 2 | 2019 | 882 | 0.150 |
Why?
|
Enzyme Inhibitors | 2 | 2012 | 3800 | 0.140 |
Why?
|
Escherichia coli | 2 | 2006 | 4214 | 0.140 |
Why?
|
Ink | 1 | 2015 | 44 | 0.130 |
Why?
|
Vitamin B 12 | 1 | 2019 | 527 | 0.130 |
Why?
|
Dimerization | 3 | 2010 | 893 | 0.130 |
Why?
|
Vinblastine | 1 | 2016 | 490 | 0.130 |
Why?
|
Fiducial Markers | 1 | 2015 | 136 | 0.120 |
Why?
|
Blood Coagulation | 1 | 2020 | 1126 | 0.120 |
Why?
|
Chelating Agents | 1 | 2015 | 380 | 0.120 |
Why?
|
Coumarins | 1 | 2014 | 119 | 0.120 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2020 | 828 | 0.110 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2018 | 2552 | 0.110 |
Why?
|
Biopsy, Fine-Needle | 3 | 2022 | 1093 | 0.110 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3130 | 0.110 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3236 | 0.100 |
Why?
|
Oxidative Stress | 1 | 2022 | 3081 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2022 | 1631 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4438 | 0.100 |
Why?
|
Spectrometry, Fluorescence | 1 | 2013 | 689 | 0.100 |
Why?
|
Erythrocytes | 1 | 2020 | 2452 | 0.100 |
Why?
|
Polymerase Chain Reaction | 1 | 2020 | 6171 | 0.090 |
Why?
|
Hydrogels | 1 | 2015 | 723 | 0.090 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2012 | 474 | 0.090 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9274 | 0.090 |
Why?
|
Neoplasms | 3 | 2023 | 21596 | 0.080 |
Why?
|
Platelet Count | 2 | 2022 | 780 | 0.080 |
Why?
|
Hemorrhage | 1 | 2020 | 3461 | 0.080 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4554 | 0.080 |
Why?
|
Antibodies | 3 | 2022 | 2459 | 0.080 |
Why?
|
Protein Multimerization | 1 | 2012 | 971 | 0.070 |
Why?
|
Mice | 7 | 2022 | 81045 | 0.070 |
Why?
|
Protein Conformation | 2 | 2006 | 4013 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2966 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5522 | 0.070 |
Why?
|
Endoscopy | 1 | 2015 | 1774 | 0.070 |
Why?
|
Chromatography, Gel | 1 | 2006 | 668 | 0.070 |
Why?
|
Animals | 10 | 2022 | 168561 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5249 | 0.060 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2006 | 713 | 0.060 |
Why?
|
Psychotic Disorders | 1 | 2019 | 3040 | 0.060 |
Why?
|
Hospitalization | 2 | 2020 | 10232 | 0.060 |
Why?
|
Humans | 19 | 2024 | 742088 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6754 | 0.050 |
Why?
|
Solutions | 1 | 2003 | 426 | 0.050 |
Why?
|
Thrombin Time | 1 | 2021 | 7 | 0.050 |
Why?
|
Chromatography, Affinity | 1 | 2023 | 549 | 0.050 |
Why?
|
Molecular Conformation | 1 | 2003 | 563 | 0.050 |
Why?
|
Models, Molecular | 3 | 2012 | 5454 | 0.050 |
Why?
|
Thermodynamics | 1 | 2003 | 594 | 0.050 |
Why?
|
Carbamates | 1 | 2022 | 195 | 0.050 |
Why?
|
Amines | 1 | 2022 | 278 | 0.050 |
Why?
|
Isomerism | 1 | 2020 | 201 | 0.050 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2003 | 507 | 0.040 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.040 |
Why?
|
Perfusion | 1 | 2023 | 1359 | 0.040 |
Why?
|
Factor VIII | 1 | 2021 | 348 | 0.040 |
Why?
|
Cell Line, Tumor | 3 | 2022 | 16665 | 0.040 |
Why?
|
Phenols | 1 | 2022 | 501 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2022 | 1583 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
Disulfides | 1 | 2020 | 457 | 0.040 |
Why?
|
Arm | 1 | 2021 | 589 | 0.040 |
Why?
|
Coronavirus | 1 | 2020 | 158 | 0.040 |
Why?
|
Young Adult | 1 | 2024 | 56350 | 0.040 |
Why?
|
Binding Sites | 1 | 2006 | 6115 | 0.040 |
Why?
|
Signal Transduction | 2 | 2018 | 23387 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2022 | 2187 | 0.040 |
Why?
|
Edema | 1 | 2021 | 790 | 0.040 |
Why?
|
Carbon | 1 | 2020 | 686 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4465 | 0.030 |
Why?
|
Ligands | 1 | 2003 | 3293 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2019 | 931 | 0.030 |
Why?
|
Deferoxamine | 1 | 2015 | 151 | 0.030 |
Why?
|
Zirconium | 1 | 2015 | 100 | 0.030 |
Why?
|
Proteins | 1 | 2010 | 6096 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12958 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1683 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1659 | 0.030 |
Why?
|
Radioisotopes | 1 | 2015 | 499 | 0.030 |
Why?
|
Immunotherapy | 2 | 2022 | 4414 | 0.030 |
Why?
|
Leukocytes | 1 | 2022 | 2039 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2015 | 677 | 0.030 |
Why?
|
Peptides | 1 | 2006 | 4392 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2006 | 3584 | 0.030 |
Why?
|
Heparin | 1 | 2021 | 1636 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2017 | 582 | 0.030 |
Why?
|
HeLa Cells | 1 | 2020 | 3127 | 0.030 |
Why?
|
Head | 1 | 2019 | 878 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2016 | 1245 | 0.030 |
Why?
|
Cell Line | 2 | 2020 | 15994 | 0.030 |
Why?
|
Patient Admission | 1 | 2020 | 1380 | 0.030 |
Why?
|
Tubulin | 1 | 2016 | 695 | 0.030 |
Why?
|
Female | 6 | 2021 | 379592 | 0.030 |
Why?
|
Folic Acid Antagonists | 1 | 2012 | 82 | 0.030 |
Why?
|
Time Factors | 2 | 2021 | 40054 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10943 | 0.030 |
Why?
|
Equipment Design | 1 | 2020 | 3582 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2022 | 2948 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2015 | 2335 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57683 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2012 | 683 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2012 | 437 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2012 | 1159 | 0.020 |
Why?
|
Male | 3 | 2024 | 349538 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2012 | 500 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8328 | 0.020 |
Why?
|
Nanotubes | 1 | 2010 | 77 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2018 | 2440 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2023 | 3507 | 0.020 |
Why?
|
Mice, Nude | 1 | 2015 | 3689 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2016 | 2699 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2012 | 1723 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3766 | 0.020 |
Why?
|
Microscopy, Atomic Force | 1 | 2008 | 248 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3557 | 0.020 |
Why?
|
Radiography | 1 | 2019 | 7010 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2012 | 1792 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9305 | 0.020 |
Why?
|
Phosphorylation | 1 | 2018 | 8436 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2015 | 1731 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2022 | 14720 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3937 | 0.020 |
Why?
|
Tacrolimus | 1 | 2010 | 741 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5872 | 0.020 |
Why?
|
Pain | 1 | 2021 | 4961 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2015 | 2410 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12344 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 2012 | 1052 | 0.020 |
Why?
|
Laparoscopy | 1 | 2015 | 2121 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2022 | 18006 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4211 | 0.010 |
Why?
|
Sirolimus | 1 | 2010 | 1562 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 77098 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10578 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2010 | 1989 | 0.010 |
Why?
|
Middle Aged | 3 | 2020 | 213127 | 0.010 |
Why?
|
Radiology | 1 | 2015 | 2090 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19223 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6259 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 21821 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23320 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20086 | 0.010 |
Why?
|
Aged | 2 | 2020 | 162944 | 0.010 |
Why?
|
Adult | 2 | 2020 | 213712 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2010 | 7721 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 62966 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 12071 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 35342 | 0.010 |
Why?
|